Clinical Trial Update: Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090 [Phase 3]

View source ↗

Summary

This is a Phase 3 extension study to evaluate long-term outcomes for subjects from Study 20090 in Retinopathy of Prematurity; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Snippet

Sponsor: Bayer | Conditions: Retinopathy of Prematurity (ROP) | Phase 3 | Status: COMPLETED